0001015155 false 0001015155 2022-11-03 2022-11-03 iso4217:USD xbrli:shares iso4217:USD xbrli:shares






Washington, D.C. 20549








Date of Report (Date of earliest event reported): November 3, 2022


Charles & Colvard, Ltd.

(Exact name of registrant as specified in its charter)


North Carolina 000-23329 56-1928817

(State or other jurisdiction of


(Commission File


(I.R.S. Employer

Identification No.)


170 Southport Drive  
Morrisville, North Carolina 27560
(Address of principal executive offices) (Zip Code)


(919) 468-0399

(Registrant’s telephone number, including area code)



(Former name or former address, if changed since last report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


Securities registered pursuant to Section 12(b) of the Act:


Title of each class Trading Symbol(s) Name of each exchange on which
Common Stock, no par value per share CTHR The Nasdaq Stock Market LLC


Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).


Emerging growth company     ¨


If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     ¨







Item 2.02 Results of Operations and Financial Condition.


On November 3, 2022, Charles & Colvard, Ltd. (the “Company”) issued a press release regarding its financial results for the fiscal quarter ended September 30, 2022. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.


Pursuant to General Instruction B.2 of Current Report on Form 8-K, the information in Item 2.02 of this report is furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Furthermore, such information shall not be deemed to be incorporated by reference into the filings of the Company under the Securities Act of 1933, as amended.


Item 9.01 Financial Statements and Exhibits.


(d)       Exhibits.


Exhibit No.   Description of Document
99.1   Press Release dated November 3, 2022
104   Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document






Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


  Charles & Colvard, Ltd.
November 3, 2022 By: /s/ Clint J. Pete
    Clint J. Pete
    Chief Financial Officer




Exhibit 99.1


A picture containing icon

Description automatically generated




$7.4 Million in Net Sales
$16.6 Million Total Cash as of September 30, 2022
85% Increase in Lab Grown Diamond Sales and 12% Decrease in Moissanite Sales on charlesandcolvard.com Versus the Year Ago Quarter
Opened First Retail Signature Showroom Location in October
Launched Lab Grown Diamond Couture and Signature Men’s Collections
Introduced Precious Colored Gemstone and Lab Grown Diamond Collection in October
Conference Call with Accompanying Slide Presentation Scheduled Today at 4:30 PM ET




RESEARCH TRIANGLE PARK, N.C. – November 3, 2022 – Charles & Colvard, Ltd. (Nasdaq: CTHR) (the “Company”), a globally recognized fine jewelry company specializing in lab created Made, Not MinedTM gemstones, reported financial results for the quarter ended September 30, 2022 (“First Quarter Fiscal 2023”), with net sales of $7.4 million and net loss of $0.03 per diluted share.


“While we remained focused on the execution of our key strategic initiatives as our fiscal year began, we faced some softness, we believe due to the current macroeconomic environment, as well as higher shipping costs and unforeseen weather-related supply chain constraints,” said Don O’Connell, President and CEO of Charles & Colvard. “Despite these conditions, this quarter we still reported the fourth highest comparable trailing twelve months revenue of over $40 million, all while maintaining $16.6 million in cash and cash equivalents and increased in-stock rates in support of the upcoming holiday season, which has traditionally been our busiest period.”


“As we position ourselves to become a leading direct-to-consumer destination for the conscious consumer, we continued to make strategic investments in our systems and infrastructure, as well as our product assortment, with exciting new collections, including Couture, Signature Men’s and, in October, our Precious Colored Gemstone and Lab Grown Diamond Collections that we believe will position us to capture a greater share of wallet appealing to a broader audience in the quarters to come,” continued O’Connell.





“In addition, we are extremely excited to have opened in October our first retail Signature Showroom location at our Company headquarters in the Research Triangle Park region of North Carolina, for those consumers who want to see our premium product in person. We believe that it remains imperative to stay top-of-mind for consumers who are seeking Made, Not MinedTM fine jewelry with a conscience, providing them with a superlative shopping experience,” concluded Mr. O’Connell.


Recent Corporate Highlights


Announced grand opening of the Company’s first retail Signature Showroom location in October;


Maintained recycled precious metals utilization of 99% for fiscal year 2022;


Executed a successful Labor Day Sale, Diamond Event and End of Summer Sale;


Launched new Couture, Signature Collection Men’s Bands and, in October, our Created Color Collections in Caydia® lab grown diamond;


Featured in twenty press publications, including BRIDES, JCK, the Robb Report, Yahoo!, Forbes, and National Jeweler; and


As of September 30, 2022, 388,403 shares of the Company’s common stock had been repurchased that are held in treasury stock for an aggregate purchase price of $489,979 dollars at an average purchase price per share of $1.26.


Financial Summary for First Quarter Fiscal 2023
(Quarter Ended September 30, 2022 Compared to Quarter Ended September 30, 2021)


Net sales of $7.4 million for the quarter, a decrease of 28% from $10.3 million in the year-ago quarter.


In the Online Channels segment, which consists of e-commerce outlets including charlesandcolvard.com, moissaniteoutlet.com, third-party online marketplaces, drop-ship retail and other pure-play, exclusively e-commerce outlets, net sales of $4.9 million, a decrease of 10% from the year-ago quarter, representing 66% of total net sales for the quarter, compared to $5.4 million, or 52% of total net sales in the year-ago quarter.


In the Traditional segment, which consists of wholesale and retail customers, net sales of $2.5 million, a decrease of 49% from the year-ago quarter, representing 34% of total net sales for the quarter, compared to $4.9 million, or 48% of total net sales, in the year-ago quarter.


Finished jewelry net sales of $5.5 million, a decrease of 3% for the quarter, compared to $5.7 million in the year-ago quarter.


Loose jewel net sales decreased 60% to $1.8 million for the quarter, compared to $4.6 million in the year-ago quarter.


Operating expenses increased 5% to $4.5 million for the quarter, compared to $4.3 million in the year-ago quarter, primarily due to increased investment in marketing strategies in preparation for the upcoming holiday season.


Income tax benefit of $303,000 for the quarter, compared to an income tax expense of $123,000 in the year-ago quarter.


Net loss was $890,000, or $0.03 loss per diluted share for the quarter, compared to net income of $827,000, or $0.03 earnings per diluted share, in the year-ago quarter.





Weighted average diluted shares outstanding were 30.4 million for the quarter, compared to 31.1 million in the year-ago quarter, partially driven by the impact of the effect of the Company's share repurchase program.


Financial Position


Cash, cash equivalents and restricted cash totaled $16.6 million as of September 30, 2022, representing a decrease of $4.6 million from $21.2 million as of June 30, 2022 and a $2.5 million decrease from the year ago quarter. Total inventory increased to $36.6 million as of September 30, 2022, compared to $33.5 million as of June 30, 2022. The Company had no debt outstanding as of September 30, 2022.


Investor Conference Call


Charles & Colvard will host an investor conference call and webcast presentation to discuss its financial results for the quarter ended September 30, 2022 at 4:30 p.m. ET on Thursday, November 3, 2022. The investor conference call and accompanying presentation slides will be webcast live and can be accessed in the Investor Relations section of the Company's website at https://ir.charlesandcolvard.com/events.


To participate via telephone, callers should dial 877-879-1183 (U.S. toll-free) or 412-902-6703 (international) and enter participant access code 5026333 a few minutes before 4:30 p.m. ET on Thursday, November 3, 2022.


A replay of this conference call will be available until November 10, 2022 at 877-344-7529 (U.S. toll-free) or 412-317-0088 (international). The replay conference ID is 5444392. The call will also be available for replay in the Investor Relations section of the Company’s website at https://ir.charlesandcolvard.com/events.


About Charles & Colvard, Ltd.


Charles & Colvard, Ltd. (Nasdaq: CTHR) believes fine jewelry can be accessible, beautiful and conscientious. Charles & Colvard is the original creator of lab grown moissanite, a rare gemstone formed from silicon carbide. The Company brings revolutionary gemstones and jewelry to market through its pinnacle Forever OneTM moissanite brand and its premium Caydia® lab grown diamond brand. Consumers seek Charles & Colvard fashion, bridal and fine jewelry because of its exceptional quality, incredible value and shared beliefs in environmental and social responsibility. Charles & Colvard was founded in 1995 and is based in North Carolina's Research Triangle Park region. For more information, please visit www.charlesandcolvard.com.


Forward-Looking Statements


This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements expressing expectations regarding our future and projections relating to our products, sales, revenues, and earnings are typical of such statements and are made under the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements about our plans, objectives, representations, and contentions and are not historical facts and typically are identified by use of terms such as “may,” “will,” “should,” “could,” “expect,” “intend,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “continue,” and similar words, although some forward-looking statements are expressed differently.





All forward-looking statements are subject to the risks and uncertainties inherent in predicting the future. You should be aware that although the forward-looking statements included herein represent management’s current judgment and expectations, our actual results may differ materially from those projected, stated, or implied in these forward-looking statements as a result of many factors including, but not limited to, (1) our business and our results of operations could be materially adversely affected as a result of general economic and market conditions; (2) our future financial performance depends upon increased consumer acceptance, growth of sales of our products, and operational execution of our strategic initiatives; (3) the effects of COVID-19 and other potential future public health crises, epidemics, pandemics or similar events on our business, operating results, and cash flows are uncertain; (4) we face intense competition in the worldwide gemstone and jewelry industry; (5) our information technology, or IT, infrastructure, and our network may be impacted by a cyber-attack or other security incident as a result of the rise of cybersecurity events; (6) constantly evolving privacy regulatory regimes are creating new legal compliance challenges; (7) we are subject to certain risks due to our international operations, distribution channels and vendors; (8) our business and our results of operations could be materially adversely affected as a result of our inability to fulfill orders on a timely basis; (9) we are currently dependent on a limited number of distributor and retail partners in our Traditional segment for the sale of our products; (10) we may experience quality control challenges from time to time that can result in lost revenue and harm to our brands and reputation; (11) seasonality of our business may adversely affect our net sales and operating income; (12) our operations could be disrupted by natural disasters; (13) sales of moissanite and lab grown diamond jewelry could be dependent upon the pricing of precious metals, which is beyond our control; (14) our current customers may potentially perceive us as a competitor in the finished jewelry business; (15) we depend on a single supplier for substantially all of our silicon carbide, or SiC, crystals, the raw materials we use to produce moissanite jewels; if our supply of high-quality SiC crystals is interrupted, our business may be materially harmed; (16) if the e-commerce opportunity changes dramatically or if e-commerce technology or providers change their models, our results of operations may be adversely affected; (17) governmental regulation and oversight might adversely impact our operations; (18) the execution of our business plans could significantly impact our liquidity; (19) the financial difficulties or insolvency of one or more of our major customers or their lack of willingness and ability to market our products could adversely affect results; (20) negative or inaccurate information on social media could adversely impact our brand and reputation; (21) we rely on assumptions, estimates, and data to calculate certain of our key metrics and real or perceived inaccuracies in such metrics may harm our reputation and negatively affect our business; (22) we may not be able to adequately protect our intellectual property, which could harm the value of our products and brands and adversely affect our business; (23) environmental, social, and governance matters may impact our business, reputation, financial condition, and results of operations; (24) if we fail to evaluate, implement, and integrate strategic acquisition or disposition opportunities successfully, our business may suffer; (25) some anti-takeover provisions of our charter documents may delay or prevent a takeover of our Company; (26) we cannot guarantee that our share repurchase program will be utilized to the full value approved, or that it will enhance long-term stockholder value and repurchases we consummate could increase the volatility of the price of our common stock and could have a negative impact on our available cash balance; and (27) our failure to maintain compliance with The Nasdaq Stock Market’s continued listing requirements could result in the delisting of our common stock, in addition to the other risks and uncertainties described in more detail in our filings with the U.S. Securities and Exchange Commission (the “SEC”), including our Annual Report on Form 10-K for the fiscal year ended June 30, 2022 and subsequent reports filed with the SEC. Forward-looking statements speak only as of the date they are made. We undertake no obligation to update or revise such statements to reflect new circumstances or unanticipated events as they occur except as required by the federal securities laws, and you are urged to review and consider disclosures that we make in the reports that we file with the Securities and Exchange Commission, or SEC, that discuss other factors relevant to our business.





Clint J. Pete, Chief Financial Officer, 919-468-0399, ir@charlesandcolvard.com


- Financial Tables Follow -





Appendix A






   Three Months Ended
September 30,
   2022   2021 
Net sales  $7,374,083   $10,280,311 
Cost of goods sold   4,086,010    5,016,550 
Gross profit   3,288,073    5,263,761 
Operating expenses:          
Sales and marketing   3,107,946    2,730,153 
General and administrative   1,413,476    1,584,275 
Total costs and expenses   4,521,422    4,314,428 
(Loss) Income from operations   (1,233,349)   949,333 
Other income (expense):          
        Interest income   40,201    355 
Loss on foreign currency exchange   -    (34)
Total other income (expense), net   40,201    321 
(Loss) Income before income taxes   (1,193,148)   949,654 
Income tax benefit (expense)   302,956    (122,629)
Net (loss) income   $ (890,192 )   $ 827,025  
Net (loss) income per common share:          
Basic  $(0.03)  $0.03 
Diluted  $(0.03)  $0.03 
Weighted average number of shares used in computing net (loss) income per common share:          
Basic   30,433,195    29,971,178 
Diluted   30,433,195    31,097,540 









   September 30, 2022   June 30, 2022 
Current assets:          
Cash and cash equivalents  $11,568,995   $15,668,361 
Restricted cash   5,054,778    5,510,979 
Accounts receivable, net   1,558,401    2,220,816 
Inventory, net   12,092,385    11,024,276 
Note receivable   -    250,000 
Prepaid expenses and other assets   1,375,093    1,190,012 
Total current assets   31,649,652    35,864,444 
Long-term assets:          
Inventory, net   24,476,083    22,488,524 
Property and equipment, net   2,196,099    1,901,176 
Intangible assets, net   265,710    265,730 
Operating lease right-of-use assets   2,638,400    2,787,419 
Note receivable   250,000    - 
Deferred income taxes, net   6,154,860    5,851,904 
Other assets   50,212    49,658 
Total long-term assets   36,031,364    33,344,411 
TOTAL ASSETS  $67,681,016   $69,208,855 
Current liabilities:          
Accounts payable  $4,718,048   $4,401,229 
Operating lease liabilities, current portion   862,401    856,571 
Accrued expenses and other liabilities   1,135,536    1,546,483 
Total current liabilities   6,715,985    6,804,283 
Long-term liabilities:          
Noncurrent operating lease liabilities   2,653,039    2,846,805 
Total long-term liabilities   2,653,039    2,846,805 
Total liabilities   9,369,024    9,651,088 
Commitments and contingencies          
Shareholders’ equity:          
Common stock, no par value; 50,000,000 shares authorized; 30,733,358 shares issued and 30,344,955 shares outstanding at September 30, 2022 and 30,778,046 shares issued and 30,747,759 shares outstanding at June 30, 2022   57,242,211    57,242,211 
Additional paid-in capital   26,052,723    25,956,491 
Treasury stock, at cost, 388,403 shares and 30,287 shares          
at September 30, 2022 and June 30, 2022, respectively   (489,979)   (38,164)
Accumulated deficit   (24,492,963)   (23,602,771)
Total shareholders’ equity   58,311,992    59,557,767 









   Three Months Ended September 30, 
   2022   2021 
Net (loss) income  $(890,192)  $827,025 
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Depreciation and amortization   137,711    124,212 
Stock-based compensation   96,232    279,407 
Provision for uncollectible accounts   -    32,000 
(Recovery of) Provision for sales returns   (36,000)   27,000 
Inventory write-downs   119,000    232,000 
Provision for accounts receivable discounts   3,250    16,419 
Deferred income taxes   (302,956)   122,158 
Changes in operating assets and liabilities:          
Accounts receivable   695,165    (1,085,046)
Inventory   (3,174,668)   (2,673,706)
Prepaid expenses and other assets, net   (36,616)   (302,985)
Accounts payable   316,819    978,534 
Accrued income taxes   -    471 
Accrued expenses and other liabilities   (598,883)   (717,057)
       Net cash used in operating activities   (3,671,138)   (2,139,568)
Purchases of property and equipment   (430,400)   (398,121)
Payments for intangible assets   (2,214)   - 
              Net cash used in investing activities   (432,614)   (398,121)
Stock option exercises   -    257,370 
Repurchases of common stock   (451,815)   - 
              Net cash (used in) provided by financing activities   (451,815)   257,370 
Supplemental disclosure of cash flow information:          
      Cash paid during the period for income taxes  $5,900   $- 


Reconciliation to Condensed Consolidated Balance Sheets: 

September 30,



June 30,


       Cash and cash equivalents  $11,568,995   $15,668,361 
       Restricted cash   5,054,778    5,510,979 
            CASH, CASH EQUIVALENTS AND RESTRICTED CASH  $16,623,773   $21,179,340